08048035996
Premium Exporter of Genuine PEG-RELIGRAST 6mg INJ  from India to Singapore – Orchard | Phoenix Exim

1. General Information

PEG-RELIGRAST 6 mg Injection is a prescription hematopoietic growth-factor medicine containing pegfilgrastim. It helps stimulate the bone marrow to produce neutrophils, a type of white blood cell important for fighting infections.

It is generally used in patients receiving chemotherapy that can significantly reduce neutrophil counts and increase the risk of febrile neutropenia.

2. Product Information

  • Brand: PEG-RELIGRAST
  • Active ingredient: Pegfilgrastim
  • Strength: 6 mg
  • Dosage form: Injection
  • Typical presentation: 6 mg/0.6 mL pre-filled syringe or injection presentation, depending on the marketed pack
  • Route: Subcutaneous injection
  • Therapeutic class: Granulocyte colony-stimulating factor (G-CSF)
  • Manufacturer/Marketer: Reliance Life Sciences
  • Storage: Refrigerate at 2°C–8°C and protect from freezing.

3. Uses of PEG-RELIGRAST 6 mg

PEG-RELIGRAST may be prescribed for:

  • Reducing the risk of febrile neutropenia associated with myelosuppressive chemotherapy.
  • Supporting recovery of neutrophil counts after chemotherapy.
  • Reducing the duration of chemotherapy-induced neutropenia.
  • Certain approved pegfilgrastim products may also be indicated following significant radiation exposure that causes bone-marrow suppression.

It should only be used for an appropriate indication under the supervision of a qualified healthcare professional.

4. Benefits of This Medicine

The main clinical benefits of pegfilgrastim include:

  • Helps increase the production of infection-fighting neutrophils.
  • Reduces the likelihood of serious infection associated with chemotherapy-induced neutropenia.
  • Helps reduce the duration of neutropenia.
  • May help reduce the occurrence of febrile neutropenia in appropriate chemotherapy patients.
  • Its long-acting formulation generally allows less frequent administration than short-acting filgrastim.

5. Side Effects

Like other prescription medicines, PEG-RELIGRAST can cause side effects. Possible adverse effects include:

  • Bone pain
  • Pain in the arms or legs
  • Joint or muscle pain
  • Headache
  • Nausea
  • Injection-site pain, redness, or irritation

Most common adverse reactions reported with pegfilgrastim products include bone pain and pain in the extremities.

Rare but potentially serious reactions can include severe allergic reactions, splenic enlargement or rupture, acute respiratory distress syndrome, kidney inflammation, thrombocytopenia, and aortitis.

6. Common Side Effects

Commonly reported effects may include:

  1. Bone pain
  2. Pain in the arms or legs
  3. Muscle or joint discomfort
  4. Headache
  5. Nausea
  6. Injection-site discomfort

If symptoms are severe, persistent, or unusual, the patient should contact their healthcare professional.

7. How to Use

PEG-RELIGRAST is administered subcutaneously (under the skin) according to the doctor's prescribed schedule.

For chemotherapy-induced neutropenia, a commonly used adult pegfilgrastim regimen is 6 mg as a single dose per chemotherapy cycle, administered at least 24 hours after completion of cytotoxic chemotherapy; the exact regimen must be determined by the treating physician and the applicable product labeling.

Do not self-administer this medicine unless a healthcare professional has specifically instructed and trained you to do so.

8. How PEG-RELIGRAST Works

PEG-RELIGRAST contains pegfilgrastim, a long-acting form of filgrastim. Pegfilgrastim acts like G-CSF, stimulating the bone marrow to produce more neutrophils. This helps restore white blood cell levels following chemotherapy and reduces the patient's susceptibility to certain infections.

The polyethylene glycol (PEG) component extends the medicine's duration in the body compared with conventional filgrastim, allowing less frequent dosing.

9. Safety Advice

  • Use PEG-RELIGRAST only on a doctor's prescription.
  • Tell your doctor about any previous allergy to pegfilgrastim, filgrastim, or related products.
  • Seek urgent medical attention for difficulty breathing, facial/throat swelling, severe rash, or other signs of a serious allergic reaction.
  • Report sudden or severe left upper abdominal or left shoulder pain, which may indicate a serious spleen-related complication.
  • Contact your healthcare professional if you develop fever, breathing difficulty, or other symptoms suggesting a serious complication.
  • Blood counts may need monitoring during treatment.
  • Store refrigerated at 2°C–8°C and do not freeze.
  • Tell your healthcare provider about all medicines and medical conditions before treatment.
  • Pregnancy and breastfeeding should be discussed with the treating physician before use.

10. Frequently Asked Questions (FAQs)

Q1. What is PEG-RELIGRAST 6 mg Injection?
PEG-RELIGRAST 6 mg is a pegfilgrastim injection used primarily to reduce the risk of infection associated with chemotherapy-induced neutropenia.

Q2. What is the active ingredient?
The active ingredient is pegfilgrastim 6 mg.

Q3. What is PEG-RELIGRAST used for?
It is mainly used to reduce the risk and duration of neutropenia and febrile neutropenia in appropriate patients receiving myelosuppressive chemotherapy.

Q4. How is PEG-RELIGRAST administered?
It is administered by the subcutaneous route, according to the healthcare professional's instructions.

Q5. Can PEG-RELIGRAST be taken without a prescription?
No. It is a prescription medicine and should be used under medical supervision.

Q6. How should PEG-RELIGRAST be stored?
It should generally be stored in a refrigerator at 2°C–8°C and should not be frozen.

Q7. What is the most common side effect?
Bone pain is among the most commonly reported adverse effects of pegfilgrastim.

Q8. Is PEG-RELIGRAST the same as filgrastim?
Both are G-CSF medicines, but pegfilgrastim is a longer-acting pegylated form of filgrastim.

11. Substitutes for PEG-RELIGRAST 6 mg

Products containing pegfilgrastim 6 mg may be considered therapeutic alternatives, but substitution should be made by a qualified healthcare professional based on the patient's condition, product authorization, and local regulations.

Examples of pegfilgrastim products marketed in India include:

  • Imupeg 6 mg Injection
  • Lupifil-P 6 mg
  • Neulastim
  • Neupeg
  • Peg Xphil
  • Pegasta
  • Pegex

The availability and regulatory status of these products can vary by country.

12. SEO Keywords

  • PEG-RELIGRAST 6 mg Injection exporter from India
  • PEG-RELIGRAST 6 mg Injection supplier
  • PEG-RELIGRAST 6 mg Injection pharmaceutical exporter
  • PEG-RELIGRAST 6 mg Injection supplier from Nagpur
  • Pegfilgrastim 6 mg Injection exporter India
  • Pegfilgrastim 6 mg Injection supplier India
  • Pegfilgrastim injection for chemotherapy-induced neutropenia
  • Pegfilgrastim 6 mg pharmaceutical supplier
  • PEG-RELIGRAST 6 mg Injection international supplier
  • Pegfilgrastim oncology medicine exporter
  • PEG-RELIGRAST 6 mg Injection for cancer treatment support
  • Pegfilgrastim 6 mg Injection exporter to USA
  • Pegfilgrastim 6 mg Injection exporter to UK
  • Pegfilgrastim 6 mg Injection exporter to Australia
  • Pegfilgrastim 6 mg Injection exporter to Singapore
  • Pegfilgrastim 6 mg Injection exporter to Canada
  • Pegfilgrastim 6 mg Injection exporter to South Korea
  • Pegfilgrastim 6 mg Injection exporter to UAE
  • PEG-RELIGRAST 6 mg wholesale
  • pharmaceutical supplier
  • PEG-RELIGRAST 6 mg bulk medicine supplier
  • Genuine pegfilgrastim 6 mg Injection supplier
  • Pegfilgrastim oncology medicine supplier from India
  • PEG-RELIGRAST 6 mg cold-chain pharmaceutical supply
  • Pegfilgrastim G-CSF injection supplier India
  • Phoenix Exim pegfilgrastim exporter Nagpur India
Aug 20th, 2026 2:16 PM

Keywords